Home > Drug Search >
  • Targets: Nitric Oxide (NO)
  •   > 
Drug Filter
Category:
chemistry (16) biology (1)
Status:
Approved (2) BLA Filing (1) Phase Ⅲ (3) Phase Ⅱ (5) Phase Ⅰ (6)
Clinical Stage:
Pending (2) Active (5) Discontinued (8)
Company:
Eisai (1) Ferring Pharmaceuticals (1) Lilly (2) Meda Pharmaceuticals (1) Merck Sharp & Dohme (1) National Cancer Institute (2) Nicox (2) Novartis (1) Perrigo (1) Roche (1) Unknown (1) Curacyte (1) NeuroGenetic Pharmaceuticals (1) Medinox (2) Orient Europharma (1) Promius (1) Ajinomoto (1) Amgen (1) Bristol-Myers Squibb (2)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Allergic rhinitis (AR) (1) Alzheimer's disease (AD) (4) Angina pectoris (2) Asthma (1) Breast cancer (1) Crohn's disease (1) Glioblastoma multiforme (1) Heart failure (1) Inflammatory bowel disease (1) Melanoma (1) Migraine (1) Myocardial infarction (MI) (1) Pancreatic cancer (2) Prostate cancer (1) Rheumatoid arthritis (RA) (1) Solid tumours (3) Type 2 diabetes (1) Colorectal cancer (1) T-cell lymphoblastic lymphoma (1) Sarcoma (1) Renal carcinoma (1) Septic shock (2) Hypotension (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top